These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 10094680)

  • 21. The curious characteristics of pyrazinamide: a review.
    Zhang Y; Mitchison D
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):6-21. PubMed ID: 12701830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant
    Rueda D; Furukawa R; Fuentes P; Comina G; Rey De Castro NG; Requena D; Gilman RH; Sheen P; Zimic M
    Int J Mycobacteriol; 2018; 7(3):275-281. PubMed ID: 30198510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
    Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
    Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escherichia coli genes involved in resistance to pyrazinoic acid, the active component of the tuberculosis drug pyrazinamide.
    Schaller A; Guo M; Gisanrin O; Zhang Y
    FEMS Microbiol Lett; 2002 Jun; 211(2):265-70. PubMed ID: 12076823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.
    Dillon NA; Peterson ND; Rosen BC; Baughn AD
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7258-63. PubMed ID: 25246400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents.
    Hegde PV; Aragaw WW; Cole MS; Jachak G; Ragunathan P; Sharma S; Harikishore A; Grüber G; Dick T; Aldrich CC
    Bioorg Med Chem; 2022 Nov; 74():117046. PubMed ID: 36228522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.
    Salfinger M; Crowle AJ; Reller LB
    J Infect Dis; 1990 Jul; 162(1):201-7. PubMed ID: 2113074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.
    Baughn AD; Deng J; Vilchèze C; Riestra A; Welch JT; Jacobs WR; Zimhony O
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5323-8. PubMed ID: 20876380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis.
    Corrêa MF; Fernandes JP
    Curr Protein Pept Sci; 2016; 17(3):213-9. PubMed ID: 26427385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.
    Njire M; Wang N; Wang B; Tan Y; Cai X; Liu Y; Mugweru J; Guo J; Hameed HMA; Tan S; Liu J; Yew WW; Nuermberger E; Lamichhane G; Liu J; Zhang T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Novel Mutations in LprG (
    Shi W; Chen J; Zhang S; Zhang W; Zhang Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
    Lanoix JP; Tasneen R; O'Brien P; Sarathy J; Safi H; Pinn M; Alland D; Dartois V; Nuermberger E
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4197-205. PubMed ID: 27139472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
    Suzuki Y; Suzuki A; Tamaru A; Katsukawa C; Oda H
    J Clin Microbiol; 2002 Feb; 40(2):501-7. PubMed ID: 11825963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with pyrazinoic acid.
    Vallejos-Sánchez K; Lopez JM; Antiparra R; Toscano E; Saavedra H; Kirwan DE; Amzel LM; Gilman RH; Maruenda H; Sheen P; Zimic M
    Sci Rep; 2020 May; 10(1):8356. PubMed ID: 32433489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides.
    Boshoff HI; Mizrahi V
    J Bacteriol; 2000 Oct; 182(19):5479-85. PubMed ID: 10986252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
    Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
    Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.